Drug Approval | January 31, 2024
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Tritan Renew, which is made with 50% certified recycled content derived from hard-to-recycle waste, performs like virgin-quality material
Combines biocompatibility, heat-resistance, transparency and durability
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
The company intends to respond to the two minor observations within the stipulated time
The registered capital of the newly founded company is € 50 million
The new campus has been designed as an employee-centred experience and ecosystem zone
Dr. Mandaviya also laid the foundation stone for an All India Institute of Speech and Hearing (AIISH) Satellite Centre in Kanpur
Hearing restoration was observed within 30 days of a single administration of AK-OTOF in the initial AK-OTOF-101 study participant
The company also plans to boost its India presence by adding 1,500 beds in the next 2-3 years
Subscribe To Our Newsletter & Stay Updated
